The following video is from Monday's Investor Beat, in which host Erin Kennedy investigates the hardest-hitting investing stories of the day with Motley Fool analysts Jason Moser and Bill Barker.
Expedia (NASDAQ:EXPE) is down about 6% today following a downgrade from Deutsche Bank citing increasing competition. Antares Pharma (NASDAQ:ATRS) popped early today -- by as much as 10% -- as investors cheered the FDA approval of Otrexup, its injection for severe active rheumatoid arthritis. Whirlpool (NYSE:WHR) stock dropped nearly 6% after a research firm said the company was unlikely to beat expectations or raise its guidance. Finally, biotech player MannKind (NASDAQ:56400P706)popped about 5% on the news that the company has resubmitted Afrezza, its ultra-rapid inhaled insulin product, for its third attempt at gaining FDA approval.
Bill Barker owns shares of MannKind. Erin Kennedy has no position in any stocks mentioned. Jason Moser has no position in any stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.